Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System

被引:127
作者
Goldberg, David S. [1 ,3 ,4 ,5 ]
Forde, Kimberly A. [1 ,3 ,4 ]
Carbonari, Dena M. [3 ,4 ]
Lewis, James D. [1 ,3 ,4 ,5 ]
Leidl, Kimberly B. F. [3 ]
Reddy, K. Rajender [1 ]
Haynes, Kevin [3 ,4 ,6 ]
Roy, Jason [3 ,4 ]
Sha, Daohang [3 ]
Marks, Amy R. [7 ]
Schneider, Jennifer L. [7 ]
Strom, Brian L. [3 ,4 ,8 ]
Corley, Douglas A. [7 ]
Lo Re, Vincent, III [2 ,3 ,4 ]
机构
[1] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA
[5] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[6] HealthCore Inc, Wilmington, DE USA
[7] Kaiser Permanente No Calif, Div Res, Oakland, CA USA
[8] Rutgers Biomed & Hlth Sci, Newark, NJ USA
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
Drug-Induced Liver Injury; Acetaminophen; Acute Liver Failure; CAUSALITY ASSESSMENT METHODS; UNITED-STATES; HEPATIC-FAILURE; INDUCED HEPATOTOXICITY; AUTOIMMUNE HEPATITIS; ADVERSE REACTIONS; INJURY NETWORK; TRANSPLANTATION; VALIDATION; OUTCOMES;
D O I
10.1053/j.gastro.2015.02.050
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
BACKGROUND & AIMS: Medications are a major cause of acute liver failure (ALF) in the United States, but no population-based studies have evaluated the incidence of ALF from drug-induced liver injury. We aimed to determine the incidence and outcomes of drug-induced ALF in an integrated health care system that approximates a population-based cohort. METHODS: We performed a retrospective cohort study using data from the Kaiser Permanente Northern California (KPNC) health care system between January 1, 2004, and December 31, 2010. We included all KPNC members age 18 years and older with 6 months or more of membership and hospitalization for potential ALF. The primary outcome was drug-induced ALF (defined as coagulopathy and hepatic encephalopathy without underlying chronic liver disease), determined by hepatologists who reviewed medical records of all KPNC members with inpatient diagnostic and laboratory criteria suggesting potential ALF. RESULTS: Among 5,484,224 KPNC members between 2004 and 2010, 669 had inpatient diagnostic and laboratory criteria indicating potential ALF. After medical record review, 62 (9.3%) were categorized as having definite or possible ALF, and 32 (51.6%) had a drug-induced etiology (27 definite, 5 possible). Acetaminophen was implicated in 18 events (56.3%), dietary/herbal supplements in 6 events (18.8%), antimicrobials in 2 events (6.3%), and miscellaneous medications in 6 events (18.8%). One patient with acetaminophen-induced ALF died (5.6%; 0.06 events/1,000,000 person-years) compared with 3 patients with non-acetaminophen-induced ALF (21.4%; 0.18/1,000,000 person-years). Overall, 6 patients (18.8%) underwent liver transplantation, and 22 patients (68.8%) were discharged without transplantation. The incidence rates of any definite drug-induced ALF and acetaminophen-induced ALF were 1.61 events/1,000,000 person-years (95% confidence interval, 1.06-2.35) and 1.02 events/1,000,000 person-years (95% confidence interval, 0.59-1.63), respectively. CONCLUSIONS: Drug-induced ALF is uncommon, but over-the-counter products and dietary/herbal supplements are its most common causes.
引用
收藏
页码:1353 / +
页数:12
相关论文
共 58 条
[1]
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[2]
International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[3]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[4]
[Anonymous], THER DRUG US
[5]
Dietary Supplement Use in the United States, 2003-2006 [J].
Bailey, Regan L. ;
Gahche, Jaime J. ;
Lentino, Cindy V. ;
Dwyer, Johanna T. ;
Engel, Jody S. ;
Thomas, Paul R. ;
Betz, Joseph M. ;
Sempos, Christopher T. ;
Picciano, Mary Frances .
JOURNAL OF NUTRITION, 2011, 141 (02) :261-266
[6]
CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .2. AN ORIGINAL MODEL FOR VALIDATION OF DRUG CAUSALITY ASSESSMENT METHODS - CASE-REPORTS WITH POSITIVE RECHALLENGE [J].
BENICHOU, C ;
DANAN, G ;
FLAHAULT, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) :1331-1336
[7]
Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis [J].
Bilasy, Shymaa E. ;
Essawy, Soha S. ;
Mandour, Mohamed F. ;
Ali, Eman A. I. ;
Zaitone, Sawsan A. .
PHARMACOLOGICAL REPORTS, 2015, 67 (01) :102-114
[8]
Outcome and prognostic markers in severe drug-induced liver disease [J].
Björnsson, E ;
Olsson, R .
HEPATOLOGY, 2005, 42 (02) :481-489
[9]
Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland [J].
Bjornsson, Einar S. ;
Bergmann, Ottar M. ;
Bjornsson, Helgi K. ;
Kvaran, Runar B. ;
Olafsson, Sigurdur .
GASTROENTEROLOGY, 2013, 144 (07) :1419-U168
[10]
Population-based surveillance for acute liver failure [J].
Bower, William A. ;
Johns, Matthew ;
Margolis, Harold S. ;
Williams, Ian T. ;
Bell, Beth P. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11) :2459-2463